Signpath Pharma Inc.
Records under this name other than the patents Signpath Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.
Showing 1 to 4 of 4 · Back to Signpath Pharma Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,138,411 | Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,004,687 | Liposomal Curcumin for Treatment of Diseases Formerly held Term ended Term ended Jul 1, 2025 · High confidence | Term ended | Term ended Jul 1, 2025 | High confidence |
| US 12,551,436 | Dosing Regimens for Treatment of Proliferative Disorders Term ended Term ended Jul 1, 2025 · High confidence | Term ended | Term ended Jul 1, 2025 | High confidence |
| US 9,170,257 | Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin Lapsed on the fee record Ended Oct 27, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2023 | From the USPTO record |